Arkema SA (OTCMKTS:ARKAY) Receives Consensus Recommendation of “Reduce” from Analysts

Arkema SA (OTCMKTS:ARKAY) has received a consensus rating of “Reduce” from the eight research firms that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, five have given a hold recommendation and one has given a buy recommendation to the company.

Several research firms recently commented on ARKAY. Berenberg Bank lowered shares of Arkema from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 20th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Arkema in a report on Tuesday. Kepler Capital Markets downgraded shares of Arkema from a “hold” rating to a “strong sell” rating in a report on Thursday, May 7th. Zacks Research raised shares of Arkema from a “strong sell” rating to a “hold” rating in a report on Monday, May 4th. Finally, The Goldman Sachs Group downgraded shares of Arkema from a “buy” rating to a “neutral” rating in a report on Monday, June 8th.

Arkema Trading Down 2.2%

Arkema stock opened at $63.73 on Friday. The firm has a 50 day simple moving average of $70.17 and a 200-day simple moving average of $66.62. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.64. The stock has a market capitalization of $4.85 billion, a PE ratio of 254.90 and a beta of 0.84. Arkema has a 12-month low of $56.28 and a 12-month high of $79.36.

Arkema (OTCMKTS:ARKAY) last posted its quarterly earnings data on Wednesday, May 6th. The basic materials company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.10. Arkema had a net margin of 0.46% and a return on equity of 4.06%. The business had revenue of $2.57 billion during the quarter, compared to analysts’ expectations of $2.52 billion. As a group, equities research analysts expect that Arkema will post 3.48 EPS for the current fiscal year.

About Arkema

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.